Merck
  • 主页
  • 查找结果
  • Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury.

Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury.

The Journal of clinical investigation (2019-11-19)
Andrew G Masoud, Jiaxin Lin, Abul K Azad, Maikel A Farhan, Conrad Fischer, Lin F Zhu, Hao Zhang, Banu Sis, Zamaneh Kassiri, Ronald B Moore, Daniel Kim, Colin C Anderson, John C Vederas, Benjamin A Adam, Gavin Y Oudit, Allan G Murray
摘要

Sustained, indolent immune injury of the vasculature of a heart transplant limits long-term graft and recipient survival. This injury is mitigated by a poorly characterized, maladaptive repair response. Vascular endothelial cells respond to proangiogenic cues in the embryo by differentiation to specialized phenotypes, associated with expression of apelin. In the adult, the role of developmental proangiogenic cues in repair of the established vasculature is largely unknown. We found that human and minor histocompatibility-mismatched donor mouse heart allografts with alloimmune-mediated vasculopathy upregulated expression of apelin in arteries and myocardial microvessels. In vivo, loss of donor heart expression of apelin facilitated graft immune cell infiltration, blunted vascular repair, and worsened occlusive vasculopathy in mice. In vitro, an apelin receptor agonist analog elicited endothelial nitric oxide synthase activation to promote endothelial monolayer wound repair and reduce immune cell adhesion. Thus, apelin acted as an autocrine growth cue to sustain vascular repair and mitigate the effects of immune injury. Treatment with an apelin receptor agonist after vasculopathy was established markedly reduced progression of arterial occlusion in mice. Together, these initial data identify proangiogenic apelin as a key mediator of coronary vascular repair and a pharmacotherapeutic target for immune-mediated injury of the coronary vasculature.

材料
货号
品牌
产品描述

Sigma-Aldrich
Nω-硝基-L-精氨酸甲酯 盐酸盐, ≥98% (TLC), powder
Sigma-Aldrich
二亚苯基碘鎓氯化物, ≥98%
Sigma-Aldrich
MISSION® esiRNA, targeting human APLNR